Abstract:Highlights • EGFR + NSCs, as a subpopulation, secrete exosomes with a more potent ability to effectively promote neural regeneration. • EGFR + NSCs-Exos enhance neural autophagy and microtubule stability via the miR-34a-5p/HDAC6-dependent pathway. • Local delivery of EGFR + NSCs-Exos using 3D-printed hydrogel patches provides a precise, cell-free treatment strategy for SCI repair. Spinal cord injury (SCI) causes severe axon damage, usually leading to permanent paraparesis, which still lacks effective regenerative therapy. Recent studies have suggested that exosomes derived from neural stem cells (NSCs) may hold promise as attractive candidates for SCI treatment. Epidermal Growth Factor Receptor positive NSC (EGFR + NSC) is a subpopulation of endogenous NSCs, showing strong regenerative capability in central nervous system disease. In the current study, we isolated exosomes from the EGFR + NSCs (EGFR + NSCs-Exos) and discovered that local delivery of EGFR + NSCs-Exos can effectively promote neurite regrowth in the injury site of spinal cord-injured mice and improve their neurological function recovery. Using the miRNA-seq, we firstly characterized the microRNAs (miRNAs) cargo of EGFR + NSCs-Exos and identified miR-34a-5p which was highly enriched in EGFR + NSCs derived exosomes. We further interpreted that exosomal miR-34a-5p could be transferred to neurons and inhibit the HDAC6 expression by directly binding to its mRNA, contributing to microtubule stabilization and autophagy induction for aiding SCI repair. Overall, our research demonstrated a novel therapeutic approach to improving neurological functional recovery by using exosomes secreted from a subpopulation of endogenous NSCs and providing a precise cell-free treatment strategy for SCI repair. Graphical abstract In this study, we identified a subtype of NSCs, named EGFR + NSCs, and extracted their exosomes, which were superior in SCI repair. We demonstrated that EGFR + NSCs-derived exosomes could cross the blood-spinal cord barrier (BSCB) and downregulate HDAC6 in neurons by delivering exosomal miR-34a-5p. And the inhibition of HDAC6 activated the autophagy pathway and promoted microtubule stability to facilitate neurite growth. It highlights that EGFR + NSCs-derived exosomes can serve as a novel therapeutic agent for spinal cord injury (SCI) repair. Download : Download high-res image (235KB) Download : Download full-size image

Local delivery of USC-derived Exosome Carrying ANGPTL3 Enhance Spinal Cord Functional Recovery After Injury by Promoting Angiogenesis

Local delivery of EGFR + NSCs-derived exosomes promotes neural regeneration post spinal cord injury via miR-34a-5p/HDAC6 pathway

Hypoxia-stimulated Mesenchymal Stem Cell-Derived Exosomes Loaded by Adhesive Hydrogel for Effective Angiogenic Treatment of Spinal Cord Injury.

Transplantation of Human Mesenchymal Stem Cell-Derived Exosomes Immobilized in An Adhesive Hydrogel for Effective Treatment of Spinal Cord Injury.

Novel multi-drug delivery hydrogel using scar-homing liposomes improves spinal cord injury repair.

Porous Microneedle Patch with Sustained Exosome Delivery Repairs Severe Spinal Cord Injury

The transforming sequences of avian myelocytomatosis virus (MC29).

Human Umbilical Cord Mesenchymal Stem Cells Derived Exosomes Promote Neurological Function Recovery in a Rat Spinal Cord Injury Model

Cutaneous tumor in a child. Cutaneous T-cell lymphoma (CTCL).

Targeted Delivery of RGD-CD146 + CD271 + Human Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes Promotes Blood–Spinal Cord Barrier Repair after Spinal Cord Injury

Preparation of Drug Sustained-Release Scaffold with De-Epithelized Human Amniotic Epithelial Cells and Thiolated Chitosan Nanocarriers and Its Repair Effect on Spinal Cord Injury

Thermos-responsive hydrogel system encapsulated engineered exosomes attenuate inflammation and oxidative damage in acute spinal cord injury

Exosomes derived from human placenta-derived mesenchymal stem cells improve neurologic function by promoting angiogenesis after spinal cord injury

Autologous exosome facilitates load and target delivery of bioactive peptides to repair spinal cord injury

Therapeutic Effect of Biomimetic Scaffold Loaded with Human Amniotic Epithelial Cell-Derived Neural-like Cells for Spinal Cord Injury.

Neural Stem Cell-Derived Exosomes Protect Spinal Cord Injury by the Transfer of miR-31-5p

Neuron-Derived Exosomes Promote the Recovery of Spinal Cord Injury by Modulating Nerve Cells in the Cellular Microenvironment of the Lesion Area

Umbilical mesenchymal stem cell-derived exosomes facilitate spinal cord functional recovery through the miR-199a-3p/145-5p-mediated NGF/TrkA signaling pathway in rats

Multiple enzyme activities of Escherichia coli MutT protein for sanitization of DNA and RNA precursor pools.

[Production of heat-labile Escherichia coli enterotoxin in a synthetic medium and its assay on a culture of Vero cells].

A method for the study of regional ischemic dysfunction in the intact dog. Permanent endocardial markers and the pressure-length loop.